EUVIMEDObjevte EUVIMED
Crossref

Clinical Efficacy and Safety of Hypericin‐Mediated Photodynamic Therapy for Oral Candida albicans Infections

Xuan Liu, Qin Luo, Jiali Ou, Yangjia Deng, Yijun Zou iD

Oral Diseases · 2026

DOI: 10.1111/odi.70240 ↗

At a glance

Journal article in Oral Diseases, 2026. Written by Xuan Liu and 4 co-authors. Institution: School of Stomatology, Changsha Medical University, Changsha, China. Major MEDLINE topics: Photochemotherapy, Anthracenes, Candidiasis, Oral, Perylene. 20 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study evaluated the efficacy and safety of hypericin‐mediated photodynamic therapy (PDT) for oral Candida albicans ( C. albicans ) infections and explores how C. albicans reduction mediates clinical improvement.

Methods

A total of 107 patients (March 2023–March 2025) were assigned to a control group ( n = 51, conventional antifungal therapy) or a study group ( n = 57, hypericin + PDT). Post‐treatment assessments included oral microbiota structure, α‐diversity (Chao1, Shannon, Simpson), community differences (via PCoA and hierarchical clustering), and a mediation model to test C. albicans ' role in lesion improvement.

Results

Chao1 (species richness) showed no significant difference, but the study group had lower Shannon/Simpson (microbial diversity). Opportunistic pathogens (e.g., C. albicans , Fusobacterium) decreased, while beneficial bacteria (e.g., Lactobacillus) increased. PCoA/clustering confirmed distinct community structures. C. albicans reduction mediated 53.1% of lesion size reduction (indirect effect = −2.656; 95% CI: 0.178–5.755).

Conclusion

Hypericin + PDT effectively treats oral C. albicans infections safely. C. albicans is the core mediator for lesion area reduction, providing a basis for targeted clinical therapy.

Subjects

MeSH terms (MEDLINE)

PhotochemotherapyAnthracenesCandidiasis, OralPerylenePhotosensitizing AgentsHumansFemaleCandida albicansMaleMiddle AgedTreatment OutcomeAged

Author keywords

Candida albicanshypericinmediation analysisoral infectionphotodynamic therapy

Substances

hypericinAnthracenesPerylenePhotosensitizing Agents

Authors and institutions

  • School of Stomatology, Changsha Medical University, Changsha, China.
  • Department of Stomatology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
  • Department of Stomatology, The First Hospital of Changsha, Changsha, China.

ORCID profiles: Yijun Zou

Cite

APA

Liu, X., Luo, Q., Ou, J., Deng, Y., & Zou, Y. (2026). Clinical Efficacy and Safety of Hypericin‐Mediated Photodynamic Therapy for Oral Candida albicans Infections. Oral Diseases. https://doi.org/10.1111/odi.70240

Vancouver

Liu X, Luo Q, Ou J, Deng Y, Zou Y. Clinical Efficacy and Safety of Hypericin‐Mediated Photodynamic Therapy for Oral Candida albicans Infections. Oral Diseases. 2026. doi:10.1111/odi.70240

BibTeX
@article{Liu2026,
  author = {Liu, Xuan and Luo, Qin and Ou, Jiali and Deng, Yangjia and Zou, Yijun},
  title = {Clinical Efficacy and Safety of Hypericin‐Mediated Photodynamic Therapy for Oral Candida albicans Infections},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70240}
}
Start for free →